OCS
NASDAQ · Pharmaceuticals
Oculis Holding Ag
$10.34
+0.20 (+1.97%)
Open$10.29
Previous Close$10.14
Day High$10.37
Day Low$10.26
52W High$34.48
52W Low$9.65
Volume—
Avg Volume187.7K
Market Cap620.50M
P/E Ratio—
EPS$-1.39
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+164.1% upside
Current
$10.34
$10.34
Target
$27.31
$27.31
$14.95
$27.31 avg
$37.18
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 335.81M | 321.14M | 281.93M |
| Net Income | 75.81M | 72.36M | 63.56M |
| Profit Margin | 22.6% | 22.5% | 22.5% |
| EBITDA | 137.16M | 117.64M | 104.92M |
| Free Cash Flow | 80.35M | 48.21M | 59.98M |
| Rev Growth | +1.2% | -6.4% | +18.4% |
| Debt/Equity | 0.56 | 0.65 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |